| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78563891A | 1991-10-31 | 1991-10-31 | |
| US785638 | 1991-10-31 |
| Publication Number | Publication Date |
|---|---|
| AU3061092Atrue AU3061092A (en) | 1993-06-07 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30610/92AAbandonedAU3061092A (en) | 1991-10-31 | 1992-10-30 | Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states |
| Country | Link |
|---|---|
| AU (1) | AU3061092A (en) |
| WO (1) | WO1993009233A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663143A (en)* | 1988-09-02 | 1997-09-02 | Dyax Corp. | Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| US5612198A (en)* | 1990-09-04 | 1997-03-18 | The Salk Institute | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| AU661844B2 (en)* | 1991-04-01 | 1995-08-10 | Merck Sharp & Dohme Corp. | Genes which influence (pichia) proteolytic activity, and uses therefor |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| ZA963619B (en)* | 1995-05-08 | 1996-11-22 | Scios Inc | Protease inhibitor peptides |
| JP3626982B2 (en)* | 1997-08-29 | 2005-03-09 | アークレイ株式会社 | Method for measuring proteolytic enzyme inhibitor and measurement kit used therefor |
| WO1999063090A2 (en)* | 1998-06-03 | 1999-12-09 | Scios, Inc. | Protease inhibitor peptides |
| US7015317B2 (en) | 2002-05-02 | 2006-03-21 | Abbott Laboratories | Polynucleotides for the detection and quantification of hepatitis B virus nucleic acids |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| DE60333758D1 (en) | 2002-06-07 | 2010-09-23 | Dyax Corp | Prevention and reduction of ischemia |
| SI2386310T1 (en) | 2002-08-28 | 2019-03-29 | Dyax Corp. | Methods for preserving organs and tissues |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| CN102307594A (en) | 2009-01-06 | 2012-01-04 | 戴埃克斯有限公司 | Treatment of mucositis with kallikrein inhibitors |
| EP4011917A1 (en) | 2010-01-06 | 2022-06-15 | Takeda Pharmaceutical Company Limited | Plasma kallikrein binding proteins |
| US8816055B2 (en) | 2011-01-06 | 2014-08-26 | Dyax Corp. | Plasma kallikrein binding proteins |
| EA201891388A1 (en) | 2015-12-11 | 2018-11-30 | Дайэкс Корп. | PLASMA KALLIKREIN INHIBITORS AND THEIR APPLICATION FOR THE TREATMENT OF THE EXPOSURE OF HEREDITARY ANGIONEUROTIC DOMESTIC |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223482A (en)* | 1986-11-17 | 1993-06-29 | Scios Nova Inc. | Recombinant Alzheimer's protease inhibitory amyloid protein and method of use |
| US5187153A (en)* | 1986-11-17 | 1993-02-16 | Scios Nova Inc. | Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| DE3912638A1 (en)* | 1989-04-18 | 1990-10-31 | Bayer Ag | GENETICALLY MANUFACTURED HOMOLOGE OF THE ALZHEIMER PROTEASE INHIBITOR, WIRSTSTAEMME AND EXPRESSION VECTORS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
| Publication number | Publication date |
|---|---|
| WO1993009233A3 (en) | 1993-08-05 |
| WO1993009233A2 (en) | 1993-05-13 |
| Publication | Publication Date | Title |
|---|---|---|
| AU3993795A (en) | Peptide compounds for prevention and/or treatment of no-mediated diseases | |
| AU3061092A (en) | Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states | |
| AU674894C (en) | Treatment of conditions and disease | |
| AU2381895A (en) | Treatment of warts using anthralins and occlusion | |
| HU9303218D0 (en) | Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia | |
| ZA938981B (en) | Human amyloid protein precursor homolog and kunitz-type inhibitor | |
| AU4230196A (en) | Treatment of pancreatic tumors with peptide yy and analogs thereof | |
| AU2161392A (en) | Methods of treating hemorrhoids and anorectal disease | |
| FI963252L (en) | Novel opioid peptides for the treatment of pain and their use | |
| AU5684594A (en) | Novel human amyloid protein precursor homologue and kunitz-type inhibitors | |
| PL331708A1 (en) | Treatment of common cold and allergic rhinitis | |
| NO971900D0 (en) | Mixtures and treatment of multiple sclerosis | |
| AU2895192A (en) | Substances having the growth-promoting effect of amyloid precursor protein | |
| FI965204A0 (en) | Medical use of bromelain | |
| AU7042796A (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
| AU1636492A (en) | Peptides having thrombospondin-like activity and their therapeutic use | |
| AU7091296A (en) | Polypeptides and their use in treatment and prophylaxis of auto-immune disease | |
| AU2299592A (en) | Treatment of periodontal disease with protease inhibitors | |
| AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
| FI963263A0 (en) | Medical use of bromelain | |
| NO921720L (en) | TREATMENT OF PREGNANCY | |
| AU1604692A (en) | Treatment of longitudinally extending members | |
| FI942941L (en) | Use of human protein C for the prevention and treatment of platelet aggregation | |
| EP0502470A3 (en) | Compounds for the treatment of inflammation and allergy | |
| GB9516572D0 (en) | Prevention and/or treatment of disease |